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Abstract  34 
CRISPR/Cas9-based genome editing has yet to be reported in species of the Platyhelminthes. We 35 
tested this approach by targeting omega-1 (ω1) of Schistosoma mansoni as a proof of principle. 36 
This secreted ribonuclease is crucial for Th2 polarization and granuloma formation. Schistosome 37 
eggs were exposed to Cas9 complexed with guide RNA complementary to ω1 by electroporation 38 
or by transduction with lentiviral particles. Some eggs were also transfected with a single 39 
stranded donor template. Sequences of amplicons from gene-edited parasites exhibited Cas9-40 
catalyzed mutations including homology directed repaired alleles, and other analyses revealed 41 
depletion of ω1 transcripts and the ribonuclease. Gene-edited eggs failed to polarize Th2 42 
cytokine responses in macrophage/T-cell co-cultures, while the volume of pulmonary 43 
granulomas surrounding ω1-mutated eggs following tail-vein injection into mice was vastly 44 
reduced. Knock-out of ω1 and the diminished levels of these cytokines following exposure 45 
showcase the novel application of programmed gene editing for functional genomics in 46 
schistosomes. 47 
  48 
Introduction 49 
Schistosomiasis is considered the most virulent of the human helminth diseases in terms of 50 
morbidity and mortality (1-6). The past decade has seen major advances in knowledge and 51 
understanding of the pathophysiology, developmental biology, evolutionary relationships and 52 
genome annotation of the human schistosomes (7-18). Establishing CRISPR/Cas9 genome 53 
editing in schistosomiasis would greatly enable effective functional genomics approaches.  The 54 
sFile CRISPR/Cas9-based site-specific gene mutation and phenotyping will drive innovation and 55 
a deeper understanding of schistosome pathogenesis, biology and evolution (19). 56 
The schistosome egg plays a central role both in disease causation and pathogenesis (1). The 57 
appearance of S. mansoni eggs in host tissues by six to seven weeks after infection coincides 58 
with profound polarization to a granulomatous, T helper type 2 (Th2) cell phenotype (20-25). 59 
Numerous egg proteins have been characterized, with >1,000 identified in a well-studied fraction 60 
termed soluble egg antigen (SEA) (26-30). In viable eggs, about 30 of the SEA proteins are 61 
located outside the developing miracidium and encompass the complement of secreted antigens 62 
(egg-secreted proteins, ESP) that interact with host tissues to facilitate the passage of the egg 63 
from the mesenteric veins to the intestinal lumen (30). The T2 ribonuclease omega-1 (ω1) is the 64 
principal Th2-inducing component of ESP with its Th2-polarizing activity dependent upon both 65 
its RNase activity and glycosylation (23, 24, 31). This RNase is hepatotoxic (32) , and its 66 
secretion by eggs into the granuloma regulates the pattern recognition receptor signaling 67 
pathways in dendritic cells that, in turn, prime Th2 responses from CD4+ T cells (33). Secreted 68 
ω1 provokes granulomatous inflammation around eggs traversing the wall of the intestines, and 69 
trapped in hepatic sinusoids and other host organs, driving fibrosis that eventually results in 70 
hepatointestinal schistosomiasis (1, 34). 71 
As ω1 drives distinctive immunological phenotypes including Th2 polarization and granuloma 72 
formation, we investigated, the use of programmed CRISPR/Cas9-mediated genome editing (35, 73 
36) to alter the ω1 locus by both gene knockout and knock-in approaches. The investigation 74 
revealed that programmable genome editing catalyzed by the bacterial endonuclease Cas9 was 75 
active in schistosomes, with chromosomal double stranded breaks (DSB) repaired by homology 76 
directed repair (HDR) using a donor, single stranded oligonucleotide template bearing short 77 
homology arms and/or by non-homologous end joining (NHEJ). The programmed mutagenesis 78 
decreased levels of ω1 mRNA and induced distinct in vitro and in vivo phenotypes, including a 79 
substantial loss of capacity of SEA from ω1-mutated eggs to polarize Th2 cytokine responses 80 
(IL-4 and IL-5) in co-cultured macrophages and T cells and loss of capacity to provoke 81 
formation of pulmonary granulomas in vivo. Functional knock-out of ω1 and the resulting 82 
immunologically impaired phenotype showcase the novel application of CRISPR/Cas9 and its 83 
utility for functional genomics in schistosomes.  84 
Results 85 
Omega-1, a multicopy locus on chromosome 1 of S. mansoni specifically expressed in eggs  86 
Five genomic copies of ω1 were identified in the S. mansoni reference genome, version 5 (Figure 87 
1—figure supplement 1) although the gene repetition at the ω1 locus on chromosome 1 presents 88 
a challenge for genome assembly. A single copy of ω1 selected for genome editing, 89 
Smp_193860, included nine exons separated by eight introns and spanned 6,196 nt (Figure 1A). 90 
Several other copies shared similar exon/intron structure and conserved coding sequences 91 
(Figure 1—figure supplement 1A and B). The predicted coding sequence (CDS) of Smp_193860 92 
encoded a ~27 kDa protein, of similar mass to the 31 kDa reported for ω1 (37). The gene 93 
encodes a secreted ribonuclease of the T2 family of transferase-type endoribonucleases with 94 
conserved catalytic regions (38). We designed a sgRNA targeting residues 3808 to 3827 of 95 
Smp_193860; within exon 6, adjacent to an AGG protospacer adjacent motif (PAM) and with 96 
the predicted Cas9 cleavage site located at three residues upstream of the PAM. (Figure 2—97 
figure supplement 1) provides the nucleotide sequence of the Smp_193860 copy, and indicates 98 
the UTR, coding exons and introns; 6,196 nt.) The AGG and the nucleotide sequence 99 
complementary to this sgRNA were also present in the Smp_179960 and Smp_184360 copies of 100 
ω1. These three copies shared >99% identity in the 202-bp PCR amplicon region sequenced for 101 
NGS although they differed by several substitutions (Figure 2—figure supplement 2A, B and C). 102 
All three copies of ω1 display a tight profile of developmental stage expression: expression is 103 
restricted to the mature egg with expression not apparent elsewhere during the developmental 104 
cycle of this schistosome (Figure 1—figure supplement 1C) (39) . 105 
Homology Directed Repair and Non-Homologous End Joining pathways in schistosomes 106 
The draft genome of S. mansoni was surveyed for key proteins of the non-homologous end 107 
joining (NHEJ) and homology directed repair (HDR) pathways. Artemis and DNA-PKcs are 108 
essential NHEJ factors in vertebrates (40-42). Candidate homologues for six of seven human 109 
NHEJ pathway genes and for two key HDR pathway genes were identified by searching for 110 
matches to Pfam (Supplement File 1). A putative homologue of Cernunnos/XLF was not 111 
apparent in S. mansoni (40) based on searching for the Pfam XLF domain (PF09302) found in 112 
human Cernunnos/XLF. The domain appears to be absent from all flatworm species studied by 113 
the International Helminth Genomes Consortium (43). 114 
Site-specific integration of transgene confirmed CRISPR-Cas9 activity in schistosomes 115 
The activity and efficiency of CRISPR/Cas9 to edit the schistosome genome, by targeting the ω1 116 
locus, was explored using two approaches. First, a ribonucleoprotein complex (RNP) comprising 117 
of sgRNA mixed with recombinant Cas9 endonuclease was delivered into schistosome eggs 118 
isolated from livers of experimentally-infected mice (eggs termed ‘LE’, ‘liver eggs’) by 119 
electroporation. In addition, Homology Directed Repair (HDR) of CRISPR/Cas9-induced double 120 
stranded breaks (DSBs) at ω1 in the presence of a donor DNA template was investigated (44-46). 121 
A single stranded oligodeoxynucleotide (ssODN) of 124 nt in length was delivered to some LE 122 
as a template for HDR of chromosomal DSBs (Figure 1B). The ssODN included a short 123 
transgene encoding six stop codons flanked by 5’- and 3’-homology arms, each arm 50 nt in 124 
length, complementary to the genome sequence of exon 6 on the 5´ and 3´ sides of the Cas9 125 
cleavage site (Figures 1A and B). In a second approach, a lentivirus vector (pLV-ω1X6; Figure 126 
1A and B) that included Cas9, driven by the mammalian translational elongation factor 1 127 
promoter, and the exon 6-targeting sgRNA (20 nt), driven by the human U6 promoter was 128 
engineered (47). LE were transduced with pseudotyped lentiviral virions (pLV) by exposure in 129 
culture to LV for 24 hours (48, 49) and, thereafter, transfected with the ssODN repair template. 130 
In both approaches, expression of ω1 in LE after 72 hours in culture was ascertained. 131 
Given that the donor ssODN included a short transgene that facilitates genotyping, PCR was 132 
performed using template genomic DNAs from the CRISPR/Cas9-treated LE (44) to reveal the 133 
site-specific knock-in (KI). A forward primer termed Sm1X6-6stp-cds-F specific for the 134 
ssODN transgene was paired with three discrete reverse primers, termed Sm1-R1, Sm1-R2 135 
and Sm1-R3, at increasing distance from the predicted HDR insertion site in ω1 (Supplement 136 
File 2). Amplicons of the expected sizes of 184, 285 and 321 nt were observed in genome-edited 137 
eggs but not in control eggs (Figure 1A and B, Figure 2—figure supplement 3A), a diagnostic 138 
pattern indicative of the ssODN transgene insertion into 1 and, in turn, indicating that the 139 
resolution of the DSB at the 1 locus from CRISPR/Cas9 had been mediated by HDR. 140 
Amplification using a control primer pair that spanned the predicted DSB, termed Sm1-control-141 
F/R, yielded control amplicons of the expected 991 nt. Similar findings were observed with 142 
genome editing delivered by RNPs and by LV (Figure 2—figure supplement 3). Sanger sequence 143 
analysis of the knocked-in amplicons (KI-R1, KI-R2 and KI-R3) confirmed the presence of the 144 
transgene inserted into 1 at the site targeted for programmed cleavage (Figure 2C). 145 
Programmed mutations in exon 6 of 1 146 
The activity of CRISPR/Cas9 was first evaluated by a quantitative PCR (qPCR) approach that 147 
relies on the inefficient binding of a primer overlapping the gRNA target, i.e. where mutations 148 
are expected to have occurred, compared to the binding efficiency of flanking primers, i.e. 149 
outside the mutated region (50, 51). The overlapping (OVR) primer pair shared the reverse 150 
primer with OUT primer (Figure 3—figure supplement 1A). Genomic DNA template was used 151 
for qPCR to quantify the efficiency of CRISPR-mediated mutagenesis at the target locus; the 152 
ratio between the OVR products and OUT products estimate the relative fold amplification 153 
reduction in CRISPR/Cas9-manipulated samples compared to controls in the target sequence of 154 
the gRNA, i.e. the annealing site for the OVR primer. Relative fold amplification was reduced by 155 
12.5% in gDNA isolated from eggs treated with pLV-ω1X6 and ssODN whereas a reduction in 156 
relative fold amplification of 2.5, 6.9, and 4.5 were observed in eggs treated with gRNA/Cas9 157 
RNP complex alone, gRNA/Cas9 RNP complex and ssODN, or pLV-ω1X6 alone, respectively.  158 
A reduction in relative fold amplification was not apparent among control groups, i.e. untreated 159 
eggs, eggs electroporated in the presence of Opti-MEM only, Cas9 only, eggs transduced with 160 
heat-inactivated pLV-ω1X6 with ssODN donor, and eggs transfected with ssODN only (Figure 161 
3—figure supplement 1B). 162 
To further characterize and quantify the mutations that arose in the genome of ω1 gene-edited 163 
eggs, we used an amplicon-next generation sequencing approach.  Barcoded amplicon libraries 164 
were constructed from pooled genomic DNA of six independent exposures of LE to pLV-ω1X6 165 
and the donor ssODN. Each amplicon was sequenced on the MiSeq Illumina platform and the 166 
CRISPResso pipeline (http://crispresso.rocks/) (52, 53) was used to analyze deep-coverage 167 
sequence reads. More than 56 million sequenced reads were compared to the reference amplicon 168 
sequence of the Smp_193860 locus (Supplement File 3), which revealed that 71% exhibited the 169 
wild type (WT; i.e., unmodified DNA) whereas 29 % reads exhibited apparent mutations (Figure 170 
2D) across the 202 bp amplicon, with 0.13% insertions, 0.58% deletions and 28.2% substitutions 171 
(Supplement File 3, sample 9). In contrast, in the control eggs-only group, 76% were WT, and 172 
24% of reads exhibited apparent mutations, with 0.14% insertions, 0.33% deletions, and 24.0% 173 
substitutions (Figure 2E, sample 2 in Supplement File 3). Thus, subtracting the rate of apparent 174 
mutations in the control, we estimated that 0.25% and 4.2% of reads in the experimental sample 175 
carried programmed CRISPR-induced deletions and substitutions, respectively. Indels of 1-2 bp, 176 
or multiples thereof, in coding DNA cause frame-shifts, and consistent with its higher rate of 177 
indels, the CRISPR/Cas9-treated sample displayed a higher rate of frame-shifts compared to a 178 
sample from control eggs, 2.0 % versus 1.4 %). 179 
Many apparent sequence variants common to the control and edited eggs likely reflect 180 
polymorphism among copies of ω1 rather than programmed mutations. The sequence reads 181 
revealed several common variants, such as adjacent ‘TA’ substitutions instead of ‘CC’ at 182 
positions 152-153 of the amplicon, which encodes a change from K to Q at the amino acid level. 183 
The gene Smp_193860 has ‘TA’ at this position in the V5 assembly (14), as does the mRNA 184 
XP_018647487.1 from the NCBI database, whereas Smp_193860, Smp_184360 and 185 
Smp_179960 all have ‘CC’ at this position in the V7 assembly (Berriman and co-workers, in 186 
preparation) (Figure 2—supplement figure 2B and C). In addition, ‘CC’ was also observed in KI 187 
fragments by Sanger direct sequencing (Figure 2C). A second common dinucleotide substitution 188 
from ‘AC’ to ‘TT’ at positions 60-61 encodes an amino acid change from T to F. Both 189 
dinucleotide substitutions occurred together in 8% of reads in the control group (Supplement File 190 
3, sample 2,) and 4% of reads in the gene-edited group (Supplement File 3, sample 9). These 191 
non-synonymous substitutions may have functional significance given their proximity to the 192 
catalytic site of the ribonuclease (Figure 2—supplement figure 2C).  193 
Along with the predicted NHEJ-catalyzed mutations, CRISPResso (http://crispresso.rocks/) 194 
determined the rate of HDR-mediated ssODN knock-in (Figure 2F and Supplement File 3). Here, 195 
insertion of the 24 bp transgene was confirmed in 0.19% of the reads at the sgRNA programmed 196 
CRISPR/Cas9 target site (Figure 2F, sample 9 in Supplement File 3). Some reads containing the 197 
knock-in sequence included the ‘CC’ to ‘TA’ substitutions at positions 152-153 and ‘AC’ to 198 
‘TT’ at positions 60-61 (Figure 2—figure supplement 2). This indicates that the indels catalyzed 199 
by NHEJ and/or KI by HDR occurred in target DNA sequences which exhibited 99% identity in 200 
multiple copies of ω1 including Smp_193860, Smp_184360 and Smp_179960, and possibly also 201 
further copies not yet annotated in the reference genome. The qPCR approach estimated a 202 
reduction by 12.5% in relative fold amplification in the pLV-ω1X6 with ssODN treatment group 203 
(Figure 3—figure supplement 1) whereas CRISPResso analysis of the pooled NGS reads 204 
indicated a frequency of indel/substitution mutation of ~4.5% (Supplement File 3). 205 
Programmed gene editing markedly diminished the expression of ω1  206 
Liver eggs (LE) transfected with RNP complexes, with or without ssODN, displayed a down 207 
regulation of the ω1-specific transcript of ~45% and 81%, respectively, compared to controls (p 208 
≤ 0.05; n = 11 by one way ANOVA). However, LE transduced with pLV-ω1X6 virions, with or 209 
without ssODN, showed a reduction of the ω1-specific transcripts of 67% and 83% respectively, 210 
when compared to controls (Figure 3A). Similar outcomes were seen in all biological replicates 211 
undertaken (n =11).  This outcome indicated that resolution of chromosomal DSB by NHEJ plus 212 
HDR provided enhanced programmed gene knockout compared to NHEJ-mediated 213 
chromosomal repair alone.  Nevertheless, both RNPs and pLV virions efficiently delivered 214 
programmed gene editing to schistosomes but lentiviral transduction delivered enhanced 215 
performance with stronger gene silencing, in particular when the donor repair template was 216 
provided (Figure 3A). When examined at later time points (days 5 and 7 following manipulation 217 
of the LE), further reduction in ω1 abundance was not apparent (Figure 3B).  218 
Large DNA deletions have been associated with CRISPR/Cas9 mutations in another helminth 219 
species (45). However, using qPCR to estimate relative copy number, as previously described 220 
(48), there were no evidence that silencing of ω1 was associated with the ω1 multiple gene copy 221 
numbers (Figure 2—figure supplement 4). 222 
Diminished ribonuclease activity in CRISPR/Cas9-mutated schistosome eggs  223 
The ribonuclease activity of the ω1 glycoprotein in SEA is associated with the Th2-polarized 224 
immune response that underpins the appearance of schistosome egg granulomata (21, 23, 24). 225 
Ribonuclease activity of SEA from control and experimental groups on substrate yeast RNA was 226 
investigated following CRISPR/Cas9 programmed mutation of ω1 mediated by the RNP and the 227 
pseudotyped lentiviral approaches with or without ssODN. Intact yeast RNA was evident in the 228 
DNase-RNase free condition (negative control), indicating absence of RNase activity in the 229 
reagents (200 ng yeast RNA at the outset). There was near complete hydrolysis of yeast RNA 230 
following exposure to RNase A (positive control); ~1.4 ng of RNA remained intact. Wild type 231 
SEA exhibited marked RNase activity against the yeast RNA; ~70 ng RNA remained intact after 232 
one hour, corresponding to >60% digestion.  Incubation of the RNA with 1-SEA (i.e., SEA 233 
from the gene edited eggs) from the experimental groups, RNP, RNP + ssODN, pLV-ω1X6, and 234 
pLV-ω1X6 + ssODN, resulted in ~30% substrate digestion, with 124, 140, 135 and 153 ng of 235 
RNA remaining, respectively. All conditions for programmed genome editing resulted in less 236 
digestion of the yeast RNA than for wild type SEA (p ≤ 0.0001) (Figures 3C, 3D). Moreover, the 237 
1-SEA with programmed knock-in exhibited less RNase activity than 1-SEA prepared 238 
without the donor ssODN repair template (p ≤ 0.01, n = 6 by one way ANOVA). 239 
Depleting SEA of ω1 down-regulated Th2 response 240 
The 1 ribonuclease alone is capable of conditioning human monocyte-derived dendritic cells to 241 
drive Th2 polarization (21) and enhanced CD11b+ macrophage modulation of intracellular toll 242 
like receptor (TLR) signaling (33, 54). Ribonuclease 1 inhibited TLR-induced production of 243 
IL-1 and redirected the TLR signaling outcome towards an anti-inflammatory profile via the 244 
mannose receptor (MR) and dectin (21, 55, 56). The human monocytic cell line, THP-1, and the 245 
Jurkat human CD4+ T cell line were employed to investigate the interaction of antigen presenting 246 
cells and T cells (57, 58). At the outset, the THP-1 cells were differentiated to macrophages for 247 
48 hours, and subsequently pulsed with SEA or 1–SEA for 48 hours. Thereafter, the Jurkat 248 
CD4+ T cells were added to the wells, and the co-culture continued for 72 hours. Representative 249 
cytokines, including IL-4, IL-5, IL-13, IL-2, IL-6, IL-10, TNF-α and IFN-γ, were quantified in 250 
supernatants of the co-cultures (Figure 4). SEA from ω1-mutated eggs reduced levels of Th2 251 
cytokines, including IL-4 and IL-5, in comparison to wild type SEA (p ≤ 0.01), and a trend 252 
towards less IL-13 production was also observed (Figure 4). Reduced levels of IL-6 and TNF-α 253 
were also observed (p ≤ 0.01, n = 4 by one way ANOVA). By contrast, significant differences in 254 
IL-10 and IL-2 were not evident between the WT- and mutant-SEA groups. IFN-γ was not 255 
detected following pulsing with the WT-SEA or mutant-SEA (Figure 4—figure supplement 1). 256 
Granulomatous inflammation markedly reduced in lungs of mice injected with 1 eggs 257 
Following the entrapment of eggs in the intestines, liver and eventually lungs, the glycosylated 258 
1 ribonuclease represents the principal stimulus that provokes the development of the 259 
circumoval granuloma, necessary for extravasation of the eggs (59). A long-established model of 260 
the schistosome egg granuloma employs tail vein injection of eggs into mice, which leads to 261 
formation of circumoval granuloma in the mouse lung (60-62). The latter approach has been 262 
extensively employed for immunopathogenesis-related studies of 1 (18). Accordingly, to elicit 263 
circumoval granulomas, ~3,000 WT or 1 LE were injected into the lateral vein of the tail of 264 
BALB/c mice. The mice were euthanized 10 days after injection, and the entire left lung was 265 
removed, fixed, sectioned, and stained for histological analysis (Figure 5). Representative digital 266 
microscopic images of the whole mouse lungs acquired through high-resolution 2D digital scans 267 
are presented in Figure 5, panels A-G. At low magnification (2×), much more severe and 268 
widespread inflammation was visible in lungs exposed to WT eggs compared to 1-eggs. In 269 
addition, markedly more intense and dense focal inflammation was induced by WT compared to 270 
1-eggs (Figure5B). Granulomas were not seen in control naïve mice not exposed to 271 
schistosome eggs (Figure5C). At 20× magnification, vast disparity in volume of the circumoval 272 
granulomas was observed for WT versus 1 LE (Figure 5A1-A2, D, E and Figures 5B1-B2, F 273 
and G). The volume of granulomas surrounding single schistosome eggs was quantified; those 274 
surrounding WT eggs in lungs of the mice were 18-fold greater than for 1-eggs, 21×10-275 
2±1.61×10-3 mm3 and 0.34×10-2 ±0.12×10-4 mm3 (mean ± S.E., 17-26 granulomas per mouse), 276 
respectively (p < 0.0001, n = 103-130 by Welch’s t-test) (Figure 5H). The experiment was 277 
repeated with 3-4 mice per group with a similar outcome. The findings documented marked 278 
deficiency in the induction of pulmonary granulomas by the 1 compared to WT eggs of S. 279 
mansoni. 280 
Discussion 281 
This report, and the accompanying article on the liver fluke Opisthorchis viverrini (63) pioneer 282 
programmed genome editing using CRISPR/Cas9 of trematodes and indeed genome editing for 283 
species of the phylum Platyhelminthes. Using S. mansoni as an exemplar, here we have 284 
demonstrated the activity and feasibility of gene knockout and knock-in in schistosomes. 285 
Programmed on-target editing was evidenced by site-specific mutations at the ω1 locus on 286 
chromosome 1. The chromosomal lesion was repaired by the non-homologous end joining 287 
(NHEJ) pathway (64) in the absence of a donor oligonucleotide and by homology directed repair 288 
(HDR) when a single stranded oligonucleotide donor template was provided (65-67). 289 
To investigate the feasibility of genome editing, schistosome eggs were transfected with 290 
ribonucleoprotein particle (RNP) complexes and with lentiviral virions carrying the 291 
CRISPR/Cas9 components, in similar fashion to earlier reports in cell lines, tissues and entire 292 
organisms (68-71). Delivery by RNPs facilitates immediate editing although the short half-life of 293 
the RNP components may be disadvantageous. Delivery by plasmids and by viral-mediated 294 
infection may provide sustained Cas9 activity, transgene integration in non-dividing cells, and 295 
other advantages (36, 72). Transfection by LV provides a hands-free approach to enable scaling 296 
of gene editing and the potential that less accessible and/or differentiated cells can be reached.  297 
To examine the efficiency of programmed genome editing, several parallel approaches were 298 
undertaken including NGS- and quantitative PCR-based analysis of pooled genomic DNAs, 299 
analysis of levels of ω1-transcripts and ribonuclease, and immuno-phenotypic status of cultured 300 
cells and of mice exposed to gene edited eggs. Analysis of the deep-coverage nucleotide 301 
sequence reads of amplicons spanning the predicted DSB site in the ω1 locus revealed that 302 
~4.5% of the reads were mutated by insertions, deletions and substitutions. The target locus was 303 
mutated by knock-in (KI) of a ssODN repair template bearing short homology arms to mediate 304 
homology directed repair following DSB at ω1, with an efficiency for HDR of 0.19% insertion 305 
of the donor transgene. Numerous substitutions in addition to deletions and insertions were seen, 306 
some of which may represent single nucleotide polymorphisms (SNPs) among the gene copies 307 
rather than genome editing-induced changes. As well as the anticipated ease of access by the 308 
RNPs, virions and the donor template ssODN, to cells proximal to the eggshell compared to the 309 
cells deeper within the egg, other factors also may have contributed to unevenness of CRISPR 310 
efficiency among the eggs and the cells within individual eggs. Given the presence of multiple 311 
copies of ω1 in the genome, the diverse organs, tissues and cells comprising the mature egg (73), 312 
the spectrum of development of the eggs in LE, and other factors, a mosaic of mutations would 313 
be expected. Some alleles might display HDR but not NHEJ, some NHEJ but not HDR, others 314 
both NHEJ and HDR, and others retain the wild type genotype. HDR proceeds at cell division, 315 
with the cell at late S or G2 phase following DNA replication where the sister chromatid serves 316 
as the repair template; otherwise, NHEJ proceeds to repair the DSB (74). 317 
If feasible, sequence analysis of individual schistosomes rather than pools of the parasites would 318 
provide more information, including transfection/transduction efficiency and parasite-to-parasite 319 
mutation rates. However, the analysis would be constrained by the number of parasites that could 320 
be investigated at the genome level in terms of effort necessary for the numerous NGS groups in 321 
the computational analysis. Here, many thousands of individual eggs were simultaneously 322 
subjected to gene editing in order to provide sufficient quantities of RNA and gDNA for the 323 
downstream transcript level and NGS-based gene editing analyses. Whereas it is technically 324 
feasible to consider analysis of individual schistosome eggs, it would be challenging to reliably 325 
recover enough nucleic acids the downstream analysis. Nonetheless, genotyping individual eggs 326 
or other developmental stages of the schistosome would be informative and straightforward to 327 
confirm the presence of transgenes following HDR of donor templates. Moreover, droplet digital 328 
PCR (ddPCR)-based analysis, a more sensitive approach than used here, is expected to provide a 329 
more sensitive and reliable quantification of gene-editing mutations. The ddPCR approach 330 
provides simultaneous assessment of both HDR and NHEJ, the repair pathways that resolve 331 
Cas9-catalyzed, double-stranded breaks, and also investigate multiple, simultaneous editing 332 
conditions at the target locus (75, 76). Recent technologies including single-cell genome 333 
sequencing will allow in the near future precisely define not only individual target cells that were 334 
mutated, but also identify which kind of mutations aroused in these individual cells (77). 335 
Expression levels of ω1 were diminished by as much as 83% relative to controls suggesting that 336 
Cas9 catalyzed the mutation of ω1, and that programmed Cas9-induced DSBs had been resolved 337 
by NHEJ and/or HDR. Knock-in of the ssODN repair template induced 81-83 % reduction in 338 
ω1-specific mRNA levels, whereas down regulation of 45 to 67 % followed the exposure of eggs 339 
to RNP or lentivirus without ssODN. Ribonuclease activity in ω1-mutated eggs was likewise 340 
significantly diminished. Curiously, less than 5% efficiency (NGS findings) in gene editing 341 
appeared to account for this markedly reduced (>80%) gene expression. The possibility of large-342 
scale deletions, as reported in Strongyloides stercoralis (45), may provide an explanation for this 343 
apparent paradox. However, analysis of copy number by qPCR failed to reveal apparent 344 
differences for copy numbers of ω1 among treatment and control groups of eggs. An alternative 345 
explanation may be the tight, stage- and tissue-specific expression of ω1. Within the mature egg, 346 
the fully developed miracidium is surrounded by a squamous, syncytial epithelium termed 347 
variously as the envelope, the inner envelope, or von Lichtenberg’s envelope (28, 30, 73, 78). 348 
The inner envelope is metabolically active (30) and is considered to be the site of synthesis of the 349 
ω1 T2 ribonuclease that is released from the egg into the granuloma (28, 30, 32) , along with 350 
other secreted/ excreted proteins that facilitate egress of the egg from the venule and through the 351 
wall of the intestine (30). Expression of ω1 is tightly, developmentally regulated: based on 352 
comparison of expression in the egg to expression in the miracidium, immunostaining and 353 
transmission electron microscopy of the mature egg, and on meta-analysis of transcriptomics 354 
sequence reads, all or most expression of ω1 occurs solely in the mature egg. Expression does 355 
not occur earlier in the embryo or immature egg or other developmental stages (24, 28, 30, 32, 356 
79, 80) (Figure 1—figure supplement 1C). The virions may have transduced only a small number 357 
of the cells within the mature egg because, following entry into the egg, the virus would be 358 
expected to first contact the inner envelope, rather than traveling further to the cells of the 359 
miracidium. Accordingly, the efficiency of gene editing may have ranged from high to low – 360 
from the exterior of the egg to its center through the cells of the egg due to ease of virus access 361 
from the culture supernatant, and displayed highest efficiency in the envelope where ω1 is 362 
expressed. In any case, this apparent paradox deserves deeper inquiry, for example by 363 
confirming the site of expression of ω1 by immunolocalization in the inner envelope of the fully 364 
mature egg.  365 
Following mating of the adult female and male S. mansoni, schistosome oviposition commences 366 
at 42 days after infection of the mouse. Thereafter the female schistosome continuously releases 367 
several hundred eggs each day. When released into the mesenteric veins from the adult female, 368 
the schistosome ovum contains a single celled zygote surrounded by ~40 vitelline cells of 369 
maternal origin (30). By six days later, the miracidium has developed within the eggshell into a 370 
multi-cellular, mobile, ciliated larva composed of organs, tissues, muscles and nerves (28, 73, 78, 371 
81). Productive infection and transmission of schistosomiasis require the translocation of the egg 372 
across the wall of the bowel. However, many eggs fail to escape from the venules and are 373 
transported by the portal circulation to the sinusoids of the liver where they become entrapped. 374 
Maturation of the egg from the single cell zygote within the eggshell at the time of oviposition to 375 
the fully mature miracidium within the eggshell takes about seven days in vitro (12, 73) and 376 
presumably a similar duration in vivo. Here, at necropsy of the mice, we anticipated that the LE 377 
preparation of eggs would include a spectrum of embryonic development of the schistosome egg 378 
from the blastula stage to mature miracidium containing organs, tissues and nerves. The fully 379 
formed egg is laid still undeveloped, without any cleavage. Once released from the female 380 
schistosome, eight embryonic stages can be defined. Stage 1 refers to early cleavages and the 381 
beginning of yolk fusion, whereas stage 8 refers to the fully formed larva, presenting muscular 382 
contraction, cilia, and flame-cell beating (73). The envelope of the egg, the site of expression of 383 
1 (28, 30) first appears at stage 3 and is developed and secretory at the later stages (73).  384 
To address the effects on the hallmark Th2 polarization of the immune response to 385 
schistosomiasis (82, 83), co-cultures of human macrophages and T cells were exposed to 1-386 
SEA and mice were exposed to 1-eggs. Whereas wild type SEA polarized Th2 cytokine 387 
responses including IL-4 and IL-5 in the co-cultures, significantly reduced levels of these 388 
cytokines were observed after exposure to ω1-mutated SEA. Moreover, following introduction 389 
of eggs into the tail vein of mice, the volume of pulmonary circumoval granulomas around Δω1 390 
eggs was enormously reduced compared to those provoked by wild type eggs. Whereas this 391 
outcome extends earlier findings using lentiviral transduction of eggs of S. mansoni to deliver 392 
microRNA-adapted short hairpin RNAs aiming to silence expression of ω1 (18), the decrement 393 
in granuloma volume was vastly more marked in the present study.  In addition to incomplete 394 
disruption of all copies of ω1, residual granulomas containing mutant eggs may be due to the 395 
presence of other Th2-polarizing components within SEA (84). Given that the T2 ribonuclease 396 
ω1 is the major type 2-polarizing protein among egg-secreted proteins (23, 24), these findings of 397 
a phenotype characterized by the absence of or diminutive pulmonary granulomas provide 398 
functional genomics support for this earlier advance (21). Nonetheless, given that 399 
hepatointestinal disease is characteristic of the infection with S. mansoni, changes in granuloma 400 
formation in the liver and intestines triggered by mutant egg will be prioritized the future studies. 401 
This study provides a blueprint for editing other schistosome genes and those of parasitic 402 
platyhelminths at large. However, hurdles remain. We suggest the following (non-inclusive) list 403 
of near term priorities with respect to development of programmed gene editing for functional 404 
genomics in flatworms: the delivery of programmed genome editing to the germ line, including 405 
transgenes than confer constitutive or conditional expression of Cas9 (85, 86); HDR-catalyzed 406 
insertion of surrogate reporter, antibiotic resistance markers (87) or antimetabolites to facilitate 407 
drug selection of the mutants (67, 88, 89); and dual guide systems (90-92). Focusing on 408 
schistosomes, establishment of lines of transgenic S. mansoni by retroviral-based transgene 409 
integration into the zygote within the newly laid egg has been described (12). Beyond the zygote, 410 
the germ line is also comparatively more accessible at several developmental stages, including 411 
the daughter sporocysts (16). Concerning somatic tissue or whole worm gene editing approaches, 412 
synchronizing the miracidial development in the cultured egg is straightforward by maintaining 413 
LE in vitro for seven days. In this way, the reproducibility of somatic editing might be improved, 414 
as mosaicism outcomes would be reduced since each mature egg enclosed the fully developed 415 
miracidium with the full complement of cells (73). For HDR, jointly supplying both anti-sense 416 
and sense long single stranded donor DNAs in trans should increase the likelihood of obtaining 417 
mutant homozygotes rather than heterozygotes (65, 93). In turn, HDR focused programmed gene 418 
editing to generate bi-allelic mutation would hasten the heriFile spread of transgenes to F2 and 419 
beyond.  420 
Gene editing the germ line followed by establishment of mutant schistosomes represents a 421 
powerful strategy to determine the role and potential fitness cost that result from deletion of the 422 
ω1 gene. However, given the established role of the ω1 T2 ribonuclease in provoking the 423 
circumoval granuloma and given the predicted role of the granuloma in translocation of the 424 
schistosome egg from the intestinal wall to the lumen of the bowel, a line of 1 schistosomes 425 
may not be transmissible via eggs shed in the host feces. Nonetheless, a line of 1 S. mansoni 426 
schistosomes might be rescued by experimentally transferring 1 eggs from livers of mice into 427 
water, for continuation of the developmental cycle.  If so, not only would this definitively 428 
demonstrate both the pathophysiological role of 1 but also would demonstrate essentiality of 429 
ω1 for successful parasitism. Mutant parasite lines can be predicted to enable more 430 
comprehensive understanding of the pathobiology of these neglected tropical disease pathogens 431 
and facilitate access to novel insights and strategies for disease management.  432 
To conclude, these findings reported here confirmed that somatic genome editing of schistosome 433 
eggs led to functional knockout of the ω1 T2 ribonuclease, and revealed the likely presence of 434 
genetic mosaicism in mutant cells resulting from gene editing (94). The genome-edited eggs 435 
exhibited loss of function of ω1 but remained viable. Programmed mutation of ω1 using 436 
CRISPR/Cas9 not only achieved the aim of establishing the applicability of genome editing for 437 
functional genomics of schistosomes but also demonstrated manipulation of a gene expressed in 438 
the schistosome egg, the developmental stage central to the pathophysiology of schistosomiasis. 439 
Materials and methods 440 
Key resources file 441 
Reagent type (species) 
or resource 
Designation Source or reference Identifiers 
Parasite S. mansoni eggs BEI resources  
Synthetic RNA Guide RNA targeting 
exon 6 of omega-1 
Thermo Fisher 
Scientific 
Custom 
Plasmid construct Lentiviral CRISPR 
cas9 construct 
containing human U6 
promoter driving 
gRNA and human 
EF1 promoter driving 
Cas9 
Sigma All-in-one vector 
(Custom) 
Oligonucleotides single strand 
oligodeoxynucleotide 
Eurofin Genomics Custom 
Streptococcus 
pyogenes, nuclease 
Cas 9 nuclease Dharmacon CAS11201 
Homo sapiens, cell 
line 
HEK293 ATCC CRL-1573, 
RRID:CVCL_0045 
Homo sapiens, cell 
line 
THP-1 ATCC TIB-202, 
RRID:CVCL_0006 
Homo sapiens, cell 
line 
Jurkat ATCC CRL-2901, 
RRID:CVCL_U620 
Commercial kit Lentiviral Packaging 
Mix 
Sigma-Aldrich SHP001 
Commercial reagent Lentiviral 
concentrator 
Takara Bio 631231 
Commercial kit Lentiviral 
quantification 
Takara Bio 631280 
Commercial kit QIAseq 1-step 
Amplicon Library kit 
Qiagen 180412 
Commercial reagent GeneRead Adaptor I Qiagen 180986 
Commercial kit QIAseq Library 
Quant System 
Qiagen QSIL-003 
Commercial kit Th1/Th2/Th17 
ELISA test kit 
Qiagen 336161 
Ethics statement 442 
Mice experimentally infected with S. mansoni, obtained from the Biomedical Research Institute 443 
(BRI), Rockville, MD were housed at the Animal Research Facility of the George Washington 444 
University Medical School, which is accredited by the American Association for Accreditation 445 
of Laboratory Animal Care (AAALAC no. 000347) and has an Animal Welfare Assurance on 446 
file with the National Institutes of Health, Office of Laboratory Animal Welfare, OLAW 447 
assurance number A3205-01. All procedures employed were consistent with the Guide for the 448 
Care and Use of Laboratory Animals. The Institutional Animal Care and Use Committee 449 
(IACUC) of the George Washington University approved the protocol used for maintenance of 450 
mice and recovery of schistosomes. Studies with BALB/c mice involving tail vein injection of 451 
schistosome eggs and subsequent euthanasia using overdose of sodium pentobarbital was 452 
approved by the IACUC of BRI, protocol 18-04, AAALAC no. 000779 and OLAW no. A3080-453 
01. 454 
Mice were euthanized seven weeks after infection with S. mansoni, livers were removed at 455 
necropsy, and schistosome eggs recovered from the livers, as described (95). The liver eggs 456 
termed ‘LE’ were maintained in DMEM medium supplemented with 10% heat-inactivated fetal 457 
bovine serum (FBS), 2% streptomycin/penicillin at 37C under 5% CO2 in air for 18-24 hours, 458 
after which LE was exposed to electroporation with RNP or transduction by LV for programmed 459 
gene editing (96, 97). Polymyxin B (10 g/ml) was added to the cultures twice daily to neutralize 460 
lipopolysaccharide (LPS) (98). Soluble egg antigen (SEA) was prepared from these eggs, as 461 
described (26, 60). In brief, the homogenate of eggs in 1PBS containing protease inhibitor 462 
cocktail (Sigma) was frozen and thawed twice, clarified by centrifugation at 13,000 rpm, 15 min, 463 
4C, the supernatant passed through a 0.22-m pore size membrane. Protein concentration of the 464 
supernatant (SEA) was determined by the Bradford Protein Assay (99) and aliquots of the SEA 465 
stored at -80C. 466 
Guide RNAs, Cas9, and single stranded DNA repair template 467 
Single guide RNA (sgRNA) was designed using the web-based tools at 468 
http://bioinfogp.cnb.csic.es/tools/breakingcas/ (100) to predict cleavage sites for the 469 
Streptococcus pyogenes Cas9 nuclease within the genome of S. mansoni. The sgRNA targeted 470 
exon 6 of the 1 gene, Smp_193860, www.genedb.org, residues 3808-3827, adjacent to the 471 
protospacer adjacent motif, AGG (Figure 1A). This is a multi-copy gene with at least five copies 472 
of 1 located in tandem on chromosome 1 (14). To infer the gene structure of Smp_193860 in 473 
the S. mansoni V5 genome assembly more accurately, the omega-1 mRNA DQ013207.1 474 
sequenced by Fitzsimmons et al. (32) was used to predict the gene structure with the exonerate 475 
software, by aligning it to the assembly using the exonerate options '--model coding2genome' 476 
and '--maxintron 1500'. The Smp_193860 copy of 1 includes nine exons interspersed with eight 477 
introns (6,196 nt) (Figure 1A). 478 
Synthetic gRNA (sgRNA), 1-sgRNA was purchased from Thermo Fisher Scientific (Waltham, 479 
MA). A double stranded DNA sequence complementary to the sgRNA was inserted into 480 
lentiviral gene editing vector, pLV-U6g-EPCG (Sigma), which encodes Cas9 from S. pyogenes 481 
driven by the eukaryotic (human) translation elongation factor 1 alpha 1 (tEF1) promoter and the 482 
sgRNA driven by the human U6 promoter (Figure 1C). (The pLV-U6g-EPCG vector is tri-483 
cistronic and encodes the reporter genes encoding puroR and GFP, in addition to Cas9 (32). This 484 
gene-editing construct, targeting exon 6 of 1 Smp_193860, was termed pLV-1X6. A single 485 
stranded oligodeoxynucleotide (ssODN) (44), which included homology arms of 50 nt each in 486 
length at the 3’ (position 3775-3824 nt) and 5’ (3825-3874 nt) flanks and a small transgene (5’-487 
TAAGTGACTAGGTAACTGAGTAGC-3’, encoding stop codons (six) in all open-reading 488 
frames) (Figure 1B), was synthesized by Eurofin Genomics (Louisville, KY). An oligonucelotide 489 
primer that included this sequence was employed in PCRs to investigate the presence of 490 
CRISPR/Cas9-programmed insertion of the transgene (Supplement File 2).  491 
Transfection of schistosome eggs with a Cas9/guide RNA complex 492 
For the ribonucleoprotein (RNP) complex of the 1-sgRNA and recombinant Cas 9 from 493 
Streptococcus pyogenes, 6 g of 1-sgRNA and 6 g of Cas9-NLS nuclease (Dharmacon, 494 
Lafayette, CO) were mixed in 100 l Opti-MEM (Sigma) to provide 1:1 ratio w/w RNP. The 495 
mixture was incubated at room temperature for 10 min, pipetted into a 4 mm pre-chilled 496 
electroporation cuvette containing ~10,000 LE in ~150 l Opti-MEM, subjected to square wave 497 
electroporation (one pulse of 125 volts, 20 milliseconds) (BTX ElectroSquarePorator, ECM830, 498 
San Diego, CA). The electroporated eggs were incubated for 5 min at room temperature, and 499 
maintained at 37C, 5% CO2 in air for 3, 5 and 7 days. To investigate whether homology-500 
directed repair (HDR) could catalyze the insertion of a donor repair template, 6 g ssODN was 501 
mixed with RNP and the LE before electroporation. In a second approach (above), the ssODN 502 
was delivered to LE by electroporation at ~24 hours after the lentiviral transduction of the LE. 503 
The eggs were collected 3, 5 and 7 days later and genomic DNA recovered from LE.  The 504 
negative controls included LE subjected to electroporation in the presence of only Opti-MEM, 505 
only Cas 9, only sgRNA, and only ssODN. 506 
Transduction of schistosome eggs with lentiviral particles  507 
Escherichia coli Zymo 5 (Zymo Research) cells were transformed with lentiviral plasmid pLV-508 
1X6 and cultured in LB broth in 100 g/ml ampicillin at 37C, agitated at 225 rpm for ~18 509 
hours, after which plasmid DNA was recovered (GenElute Plasmid purification kit, Invitrogen).  510 
A lentiviral (LV) packaging kit (MISSION, Sigma-Aldrich) was used to prepare LV particles in 511 
producer cells (human 293T cell line).  In brief, 3.5  105 of 293T cells/well were seeded in a 6-512 
well tissue culture plate in DMEM supplemented with 10% heat- inactivated fetal bovine serum 513 
(FBS), 2 mM L-glutamine, 1% penicillin/streptomycin and cultured at 37C, 5% CO2 for 18 514 
hours. The producer cells were transfected using FUGENE HD (Promega) with pLV-1X6 and 515 
LV packaging mix containing two additional plasmids; one plasmid that expressed HIV 516 
structural and packaging genes and another that expressed the pseudotyping envelope protein 517 
Vesicular Stomatitis Virus Glycoprotein (VSVG). Subsequently, the transfection mixture (50 l; 518 
500 ng plasmid DNA, 4.6 l packaging mix, 2.7 l of FUGENE HD in Opti-MEM) was 519 
dispensed drop wise into each well on the plate. Sixteen hours later, the media were removed 520 
from the transfected cells, replaced with pre-warmed complete DMEM, and cells cultured for 24 521 
hours. The supernatant, containing VSVG-pseudotyped LV particles was filtered through 22 m 522 
pore size membranes (49) , and stored at 4C. Additional pre-warmed complete DMEM was 523 
added to the well, for culture for a further 24 hours. The supernatant was collected as above, 524 
combined with the first supernatant and concentrated (Lenti-X concentrator, Takara Bio, 525 
Mountain View, CA). Virion titer was estimated by two methods; first, by use of Lenti-X-GoStix 526 
(Takara Bio) to establish the presence of functional virions at >105 infectious units (IFU)/ml, and 527 
second, by reverse transcriptase assay (49, 101) to quantify levels of active virions. Virions with 528 
counts of ~4106 count per minute (cpm)/ml were aliquoted and stored at -80C. 529 
To transduce LE with LV, ~10,000 eggs were incubated for 24 hours in complete DMEM 530 
containing 500 l of ~4106 cpm/ml VSVG-LV virions. Thereafter, the LE were washed three 531 
times in 1PBS and transfected with ssODN (6 g) by square wave electroporation.  The further 532 
steps (102) with subsequent transfection with heat-inactivated pLV virions at 70C for four hours 533 
with ssODN, transfection with ssODN in the absence of virions or Opti-MEM only served as 534 
negative controls. 535 
PCR amplification of diagnostic transgene to detect knock-in into exon 6 of 1 536 
For each DNA sample, four separate PCR assays using four distinct primer pairs (Supplement 537 
File 2) were carried out. The first ω1 primer pair, to amplify locations 3751-4740 nt of 538 
Smp_193860, was employed as positive control for the presence of genomic DNA with the 539 
Smp_193860 copy of 1. The other primer pairs shared one forward primer complementary to 540 
the knock-in 24 nt transgene with three reverse primers, Sm ω1-R1, -R2 and -R3 at positions 541 
3966-3984, 4066-4085 and 4102-4121 nt, respectively, binding to three sites downstream of the 542 
1 predicted DSB site (Figure 2A, Supplement File 2) (44). The PCR mix included 10 l Green 543 
GoTaq DNA polymerase mix (Promega) with 200 nM of each primer and 10 ng genomic DNA.  544 
Thermal cycling conditions involved denaturation at 95C, 3 min followed by 30 cycles of 94C, 545 
30 seconds, 60C, 30 seconds and 72C, 30 seconds and a final extension at 72C for 5 minutes. 546 
Following agarose gel electrophoresis (1.2% agarose/TAE), amplicons of the expected sizes 547 
were recovered from gels and ligated into pCR4-TOPO (Thermo Fisher). E. coli Zymo 5α 548 
competent cells were transformed with the ligation products, several colonies of each 549 
transformant were grown under ampicillin selection, plasmid DNA purified, and the inserts 550 
sequenced to confirm the presence and knock-in of the transgene (Figure 1C). 551 
Estimation of mutation efficiency  552 
We used the egg genomic DNA templates directly for qPCR as described (51) , with slight 553 
modification which enabled estimation of the efficiency of CRISPR-mediated mutagenesis at the 554 
target locus without the need to normalize the experimental and control template DNAs. The 555 
general approach makes use of the fact that the binding of a primer overlapping the sgRNA site 556 
was compromised in programmed mutagenized egg (LE) genome(s), resulting in delayed 557 
amplification, whereas binding of a flanking primer pair was unaffected. The ‘OUT’ (flanking) 558 
primer pair encompassed at least 50 bp surrounding the sgRNA binding region. The ‘OVR’ 559 
(overlapping) primer pair used one of the Sm1-OUT primers and another primer that bound the 560 
20 bp of the sgRNA target sequence. The 3′ side of the Sm1-OVR primers bound immediately 561 
upstream of the NGG motif, as the majority of indels would be expected to affect positions -1 to 562 
-10 of the binding site (53).  563 
At days 3, 5 and 7 following transfections with or without ssODN, genomic DNA was isolated 564 
from LE. Using 5 ng of DNA template, separate 20 μl OUT and OVR qPCR reactions were 565 
undertaken. Quantitative PCR was performed with SsoAdvanced SYBR Green Supermix (Bio-566 
Rad, 172-5271) using a Bio-Rad iQ5 Real-Time PCR system, with qPCR conditions at initial 567 
95°C for 30 s, 40 cycles, 95°C for 10 s, 60° C for 20 s. Oligonucleotide primer sequences are 568 
provided in Supplement File 2. 569 
The ratio of the qPCR quantification cycle values for the control Sm1-OVR and control Sm1-570 
OUT primers reflected the differences in amplification of the two primer pairs on control DNA 571 
template. This might have been due to inherent differences in amplification that exist even 572 
between perfectly complementary primer pairs. In contrast, the OVR/OUT ratio in mutant DNA 573 
reflected both this difference in amplification between the primer pairs and the loss of the OVR 574 
binding site due to CRISPR-introduced indels. A comparison of the OVR/OUT quantification 575 
cycle ratios of control versus mutated genomes thus reflected the efficiency of mutagenesis. The 576 
CRISPR efficiency was calculated by the Ct ratio of OVR:OUT, after which indel/substitution 577 
mutation percentage was estimated as follows: 578 
 % Relative fold amplification     = 100  (B/A) 579 
     A = Ct ratio of OVR:OUT from control group 580 
     B = Ct ratio of OVR:OUT from experiment group 581 
Illumina sequencing 582 
Pooled LE DNA samples from six independent KI experiments of pLV-ω1X6 with ssODN were 583 
used as the template to amplify the on-target DNA fragment using MiSeq primers (Figure 2A) 584 
with High Fidelity Taq DNA polymerase (Thermo Fisher). PCR reactions were set up with 10 ng 585 
LE DNA samples from the KI experiment in 25 µl reaction mix using the HiFidelity Taq DNA 586 
polymerase (Thermo Fisher) following the PCR program 94ºC for 3 minutes of denaturation 587 
followed by 30 cycles of 94ºC for 30 seconds, 60ºC or 54ºC for 30 seconds, 72ºC for 45 seconds 588 
and final extension at 72ºC for 2 minutes. The expected size of the amplicon flanking predicted 589 
DSB was 202 bp. Amplicons of this size were purified using the Agencourt AMPure XP system 590 
(Beckman Coulter). Amplicons generated from four different PCR reactions from each sample 591 
were pooled, and 100 ng of amplicons from each sample was used to construct the uniquely 592 
indexed paired-end read libraries using the QIAseq 1-step Amplicon Library Kit (Qiagen) and 593 
GeneRead Adapter I set A 12-plex (Qiagen). These libraries were pooled, and the library pool 594 
was quantified using the QIAseq Library Quant System (Qiagen). 595 
Samples (Supplement File 3) were multiplexed (10 samples) and each run on four MiSeq lanes. 596 
After sequencing, the fastq files for each particular sample were merged. Samples 1-6, 8 and 10 597 
were prepared using an annealing temperature of 54ºC. Samples 7 and 9 were prepared using an 598 
annealing temperature of 60ºC, and included an extra 10 bp at the start of the MiSeq sequences, 599 
‘GTTTTAGGTC’, present upstream of the 5’ primer in the genomic DNA. We trimmed this 600 
sequence from the reads using cutadapt v1.13 (103). To detect HDR events, computational 601 
software program CRISPResso (http://crispresso.rocks/) (52, 53) was employed using a window 602 
size of 500 bp (-w 500) with the reference amplicon according to gene Smp_193860 in the S. 603 
mansoni V7 assembly, and with the --exclude_bp_from_left 25 and --exclude_bp_from_right 25 604 
options in order to disregard the (24 bp) primer regions on each end of the amplicon when indels 605 
are being quantified. A window size of 500 nt was employed to include the entire amplicon. In 606 
order to search for HDR events, CRISPResso checked for HDR events (using –e and –d options) 607 
in treatment groups including controls. To infer frameshifts using CRISPResso the –c option was 608 
used, giving CRISPResso the coding sequence from positions 42-179 of the amplicon. To 609 
confirm the insertions of the knock-in sequences reported by CRISPResso (right side column in 610 
Supplement File 3), we took all insertions of 20-28 bp reported by CRISPResso, and calculated 611 
their percent identity to the expected knock-in sequence using ggsearch v36.3.5e in the fasta 612 
package (104). An insertion was considered confirmed if it shared ≥75% identity to the expected 613 
donor knock-in sequence. 614 
GenBank/EMBL/DDBJ 615 
Database accessions Sequence reads from the amplicon NGS libraries are available at the 616 
European Nucleotide Archive, study accession number ERP110149. Additional information is 617 
available at Bioproject PRJNA415471, https://www.ncbi.nlm.nih.gov/bioproject/PRJNA415471 618 
and GenBank accessions SRR6374209, SRR6374210. 619 
Copy number estimation for ω1 620 
A quantitative PCR to estimate the relative copy number of ω1 was performed using Kapa qPCR 621 
mastermix SYBRfast (KK4602) on 1 ng of gDNA templates (pooled genomic DNA samples 622 
from 6 biological replicates) isolated from control and test samples, in 20 l volumes. A primer 623 
pair of OMGgRNA1F and OMGgRNA1R was used to amplify the ω1 gRNA target region and 624 
SmGAPDH (Supplement File 2) as a reference single-copy gene (primers shown in Supplement 625 
File 2). The PCR efficiencies for primer pairs were estimated by titration analysis to be 100% ±5 626 
(105) and qPCRs were performed in triplicate in 96-well plates, with a denaturation step at 95C 627 
of 3 min followed by 40 cycles of 30 sec at 95C and 30 sec at 55C, in thermal cycler fitted 628 
with a real time detector (StepOnePlus, Applied Biosystems). The relative quantification assay 2-629 
Ct method (106) was used to ascertain the relative copy number of ω1.  Relative copy number 630 
of ω1 in the CRISPR/Cas9 treated groups reflects the fold change of ω1 copy number 631 
normalized to the reference gene (Sm GAPDH-F and -R primers) and relative to the untreated 632 
control group (calibrator sample with relative ω1 copy number = 1). 633 
Gene expression for 1 mRNA  634 
Total RNAs from schistosome eggs were extracted using the RNAzol RT reagent (Molecular 635 
Research Center, Inc), which eliminates contaminating DNA (107) , and concentration and 636 
purity determined using a spectrophotometer (OD260/280 ~2.0).  Reverse transcription (RT) of the 637 
RNA (500 ng) was performed using iScript Reverse Transcript (Bio-Rad), after which first 638 
strand cDNA was employed as template for qPCRs using SsoAdvanced Universal SYBR Green 639 
Supermix (Bio-Rad) performed in triplicates in an iQ5 real time thermal cycler (Bio-Rad). RT-640 
qPCR reaction mixtures included 2 l first strand cDNA, 5 l SsoAdvanced Universal SYBR 641 
Green Supermix, and 300 nM schistosome gene specific primers. Supplement File 2 provides 642 
details of the oligonucleotide primers. Thermal cycling included denaturation at 95C for 30 sec, 643 
40 amplification cycles each consisting of denaturation at 95C for 15 sec and 644 
annealing/extension at 60C for 30 sec, and a final melting curve. The output was analyzed using 645 
the iQ5 software (BioRad).  Relative expression was calculated using the 2-Ct method and 646 
normalized to schistosome GAPDH expression (106); data are presented as transcript levels 647 
(three replicates) compared to the wild type LE (100%), and fold change reported as mean 648 
relative expression  SD (n =11). 649 
Nuclease activity of 1  650 
A stock solution of yeast RNA (Omega Bio-tek, Norcross, GA) was prepared at 1.0 g/l, 50 651 
mM Tris-HCl, 50 mM NaCl, pH 7.0. Yeast RNA (200 ng) was incubated with 2 g SEA from 652 
control and experimental groups individually at 37C for 60 min. SEA investigated here, named 653 
1-SEA, was extracted from LE transduced with pLV- ω1X6 virions and ssODN, pooled from 654 
six biological replicates. RNase A, an endoribonuclease from bovine pancreas (Thermo Fisher) 655 
served as a positive control enzyme whereas yeast RNA in reaction buffer only served as the 656 
negative control. The RNase activity of 1 in wild type SEA or 1-SEA was analyzed by 657 
visualizing and quantifying the substrate that remained following enzymolysis by agarose gel 658 
electrophoresis and staining with ethidium bromide. The yeast RNA digestion by control SEAs 659 
or 1-SEA were set up in triplicates, with quantity of residual RNA determined by 660 
densitometry (108). 661 
Macrophage polarization by WT or 1-SEA and T-cell activation in vitro 662 
Human monocytic THP-1 cells were maintained in Roswell Park Memorial Institute medium 663 
(RPMI) 1640 (Thermo Fisher Scientific) containing 10% (v/v) FBS with 4 mM L-glutamine, 25 664 
mM HEPES, 2.5 g/L D-glucose at 37C in 5% CO2 in air.  THP-1 cells were non-adherent cells. 665 
In a 6-well plate, THP-1 monocytes (3105 cells in each well) were differentiated into 666 
macrophages (Mϕ) by incubation in 150 nM phorbol 12-myristate 13-acetate (PMA) (Sigma) for 667 
48 hours (109). Mϕ were exposed to SEA (50 ng/ml) or 1-SEA (50 ng/ml) (from LE 668 
transduced with pLV-1X6 virions and ssODN) for 48 hours. To investigate macrophage and T 669 
cell interactions, Mϕ cells were pulsed with 50 ng/ml SEA or 1-SEA and thereafter co-670 
cultured in direct contact with Jurkat (human CD4+ T) cells. Nine 105 Jurkat were added to Mϕ 671 
with direct contact and were co-cultured for an additional 72 hours. Cell-free supernatants from 672 
the co-cultures were collected to quantify secretion of T helper cell cytokines including IL-4, IL-673 
5, IL-13, IL-10, TNF-, IL-6, IL-2 and IFN- by enzyme linked immunosorbent assay 674 
(Multiplex Human Cytokine ELISA kit, Qiagen) (110). The assay included positive controls for 675 
each analyte, which were provided in the kit. Three biological replicates were undertaken. 676 
Cell lines 677 
Human HEK293 cells, Jurkat and THP-1 cell lines were obtained from ATCC. All three cell 678 
lines were authenticated by ATCC using STR profiling by PCR and were confirmed in our 679 
laboratory to be Mycoplasma-free using the Lookout Mycoplasma PCR detection kit (Sigma-680 
Aldrich). 681 
Schistosome egg-induced primary pulmonary granulomas  682 
For induction of circumoval, egg-induced granulomas in the lungs of mice, 8 week old female 683 
(28) BALB/c mice were injected with 3,000 WT eggs or Δω1-eggs (from experiment pLV-ω1X6 684 
with ssODN) or 1PBS as negative control by tail vein, as described (62). The mice were 685 
euthanized 10 days later. Each group included 3 or 5 mice, two biological replicates were 686 
undertaken, totaling 6-10 mice for each treatment group. Before starting the experiment, mice 687 
were allocated randomly to the control or experimental treatment groups. For histopathological 688 
assessment of granuloma formation, the left lung was removed at necropsy and fixed in 10% 689 
formalin in pH 7.4 buffered saline for 24 hours, after which it was dehydrated in 70% ethanol, 690 
and clarified in xylene. The fixed lung tissue was embedded in paraffin and sectioned at 4-μm-691 
thickness by microtome. Thin sections of the left lung lobe were mounted on glass slides and 692 
fixed at 58-60°C. Subsequently, rehydrated sections were stained with hematoxylin-eosin (H&E) 693 
for evaluation of inflammatory infiltrates and cellularity of granulomas. Digital images were 694 
captured using a 2D glass slide digital scanner (Aperio Slide Scanner, Leica Biosystems, Vista, 695 
CA) and examined at high magnification using the Aperio ImageScope software (Leica) (61, 696 
111). The longest (R) and shortest (r) diameters of each granuloma containing a single egg were 697 
measured with an ocular micrometer, and the volume of the granuloma calculated assuming a 698 
prolate spheroidal shape, using 4/3 π Rr2 (28). All granulomas in all slides from the left lung of 699 
the mice, 15 slides per treatment group, were measured; in total, >100 granulomas from each 700 
treatment group. 701 
Biological and technical replicates, statistics 702 
In the assays above, we performed two or more biological replicates. These biological replicates 703 
represented parallel measurements of biologically discrete samples in order to capture any 704 
random biological variation. Technical replicates were undertaken as well; these represented two 705 
or three repeated measurements of the same sample undertaken as independent measurements of 706 
the random noise associated with the investigator, equipment or protocol.  707 
Means for experimental groups were compared to controls by one-way ANOVA and, where 708 
appropriate, by two-tailed Student’s t-test and Welch’s unequal variances t-test (GraphPad 709 
Prism, La Jolla, CA). Values for p of ≤ 0.05 were considered to be statistically significant. 710 
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  990 
Figure legends 991 
Figure 1.  A, Genomic structure of the locus encoding omega-1 (1) in the genome of S. 992 
mansoni, guide RNA and CRISPR/Cas9 encoding construct. Gene model of 1 (Smp_193860), 993 
showing the position of its nine exons, eight introns and UTRs 6,196 bp on chromosome 1. B, 994 
Nucleotide sequence in exon 6 indicating location and sequence of gRNA target site, predicted 995 
double stranded break (DSB) (arrow), protospacer adjacent motif (PAM) (AGG, blue box), and 996 
124-nucleotide sequence of the single stranded DNA donor template provided for DSB repair by 997 
homologous recombination. Homology arms of 50 nt flank a central 24 nt of six-stop-codon 998 
transgene. C, Linear map of pLV-1X6 showing position of regulatory and coding regions for 999 
CRISPR/Cas9 editing; the positions of the human U6 promoter to drive 1 gRNA, the 1000 
translational elongation factor EF1-α promoter driving Cas9 from S. pyogenes, and the left and 1001 
right long terminal repeats of the lentiviral vector derived from HIV-1. 1002 
Figure 2. Programmed chromosomal break at 1 locus repaired by homologous recombination 1003 
from donor template.  A, Schematic diagram to indicate positions of primer binding sites (blue 1004 
arrows), with the foreign gene cassette as the forward primer (Smω1X6-6-stop codons cassette-1005 
F) paired with three discrete reverse primers, Smω1-R1, Smω1-R2 and Smω1-R3 from the 1 1006 
locus and a primer pair for target amplicon NGS library amplification; miSeq-F and miSeq-R. 1007 
The control PCR amplicon was generated using the Sm1-control-F and –R primers. The green 1008 
box shows the location of 5’ and 3’ homology arms, the red box and arrow indicate the stop 1009 
codon bearing transgene. B, PCR products visualized in ethidium bromide-stained agarose gel 1010 
demonstrating Cas9-catalyzed target site-specific insertional mutagenesis in exon 6 of the 1 1011 
gene. Evidence for transgene knocked-in into programmed target site revealed by amplicons of 1012 
the expected sizes in lanes R1, R2 and R3, of 184, 285 and 321 bp, respectively (arrows at left) 1013 
spanned the mutated site in the genomic DNAs pooled from schistosome eggs, including a 1014 
positive control flanking the insert site (991 bp).  The control DNA result shown in this gel was 1015 
isolated from heat-inactivated-pLV-1X6 virions and ssODN treated LE.  Similar findings were 1016 
obtained when programmed gene editing was executed by lentiviral virion-delivered Cas9 and 1017 
1-gRNA transgenes and by ribonucleoprotein complex (RNP) delivered by square wave 1018 
electroporation (supporting information). The non-KI control groups (sgRNA only, heat-1019 
inactivated pLV-1X6 virions only, ssODN only) showed no amplicons by stop cassette-KI 1020 
primers with R1, R2 or R3. C, Multiple sequence alignments confirmed the presence of the 24 nt 1021 
transgene inserted precisely into exon 6 of 1 locus from KI-R1, -R2 and -R3 fragments 1022 
compared with 1 wild type (WT). The white box on 1-WT indicates the absence of the 1023 
transgene sequence and white boxes on KI-R1, -R2 and –R3 fragments show locations of 1024 
substitutions relative to the other 1 copies (Smp_184360): 2 bp (AT to CC) mismatches at 1025 
positions 253-254 nt.  All three contained the (knock-in) insertion sequence (white box), which 1026 
confirmed targeted mutation of the 1 gene. D-F, Illumina deep sequence analysis of amplicon 1027 
libraries revealed Cas9 induced on-target repair of programmed gene mutation of the 1 locus 1028 
by deletions, insertions, and substitutions by CRISPResso analysis. D; position dependent 1029 
deletion size (deletion site, X-axis; deletion size, Y-axis); the deletions varied in length from 1030 
point mutations to >20 bp adjacent to the DSB. The dotted line indicates the predicted position of 1031 
the programmed double stranded break. E, frequency of frameshift versus in-frame mutations 1032 
reported by CRISPResso. The pie charts show the fraction of all mutations (indels and 1033 
substitutions) in the coding region (positions 42-179) of the amplicon predicted to induce 1034 
frameshifts, i.e. indels of 1-2 bp, or multiples thereof. Top graph corresponds to sample 2 (eggs 1035 
only control) (Supplement File 3), bottom graph corresponds to sample 9 (eggs exposed to 1036 
virions and ssODN, i.e. CRISPR/Cas9-treated) (Supplement File 3). Findings for control and 1037 
treated samples are provided in Supplement File 3. F, Frequency distribution of insertions of the 1038 
knock-in transgene. Number of amplicon reads containing an insertion of the knock-in sequence 1039 
(with ≥75% identity to it) is shown in the Y-axis, and the position of the insertion relative to the 1040 
reference amplicon is shown on the X-axis. The programmed Cas9 scission lies between 1041 
positions 102 and 103. Samples 3, 7 and 9 are independent amplicon libraries (technical 1042 
replicates) made from the same sample of genomic DNA pooled from six biological replicates 1043 
exposed to virions and ssODN. The insert shows a sequence logo, created using WebLogo (112) 1044 
, of the sequences of the 3,826 sequence reads from samples 3, 7 and 9, with insertions of 24 bp 1045 
at position 102; most matched the donor template, TAAGTGACTAGGTAACTGAGTAGC. 1046 
Figure 3. Diminished 1-specific transcript levels and ribonuclease T2 activity following 1047 
programmed editing.  A, 1 mRNA abundance reduction up to ~ 70% after genome editing by 1048 
sgRNA/Cas9 complex and lentivirus systems, and markedly reduced >80% with the addition of 1049 
ssODN as the DNA repair donor.  Relative expression of 1 transcripts at three days following 1050 
CRISPR/Cas9 manipulation; mean ±SD, n =11 (biological replicates); p ≤ 0.0001 (****) 1051 
ANOVA statistic significant.  B, SFile reduction of 1 transcripts at days 5 and 7 after treatment 1052 
(three biological replicates) in four experimental groups; RNP (black), RNP and ssODN (red), 1053 
pLV-1X6 virions (green), pLV-1X6 virions and ssODN (blue) compared to controls. C-D, 1054 
Loss of RNase activity as assessed by hydrolysis of yeast RNA. Residual yeast following 1055 
exposure to SEA, visualized after gel electrophoresis; DW (negative control), RNase A, control 1056 
SEA (from wt LE), other negative control SEAs; mock, sgRNA only, cas9 only, heated-pLV-1057 
1X6 + ssODN and the Δ1-SEAs from RNP, RNP with ssODN, pLV-1X6 virions, and pLV-1058 
1X6 virions with ssODN. D, Intact yeast RNA (nanograms) remaining following incubation 1059 
with SEA (mean ±SD, n = 6). More RNA remained following incubation with Δ1-SEA in all 1060 
groups, RNP, RNP and ssODN, pLV-1X6 virions, and pLV-1X6 virions and ssODN treated 1061 
SEA) (blue) than in the WT SEA controls (p ≤ 0.0001). Among the gene edited experimental 1062 
groups, more RNA remained when donor template was introduced at the same time as RNP or 1063 
pLV-1X6 virions (p ≤ 0.01, n = 11 by ANOVA). Significant differences were not apparent 1064 
among the WT SEA control groups. 1065 
Figure 4. Reduced Th2 cytokine levels following exposure to Δω1-SEA.  Reduction in Th2 1066 
cytokines IL-4 and IL-5 but not IL-13 following pulsing of Mϕ (PMA induced-THP-1 cells) with 1067 
Δω1-SEA prior to co-culture with human CD4+ T cells (Jurkat cell line) compared with WT-1068 
SEA pulsed-Mϕ (top panels). In addition, levels of IL-6 and TNF-⍺ were reduced where Mϕ 1069 
were first pulsed with Δω1-SEA but not WT SEA. Differences were not evident for IL-10. The 1070 
assay was carried out in triplicate; p < 0.0001, ≤ 0.0001, 0.0038 and 0.0252 indicated as ****, 1071 
***, ** and *, respectively (one-way ANOVA, multiple comparison, n = 4). 1072 
Figure 5. Pulmonary circumoval granulomas revealed attenuated granulomatous response to 1073 
Δω1 schistosome eggs. Schistosome eggs (~3,000 eggs) that had been transduced with lentivirus 1074 
virions encoding ω1-specific sgRNA and Cas9 in tandem with ssODN were introduced via the 1075 
tail vein into mice. The mice were euthanized 10 days later; thin sections of the left lung were 1076 
stained with H&E, and circumoval granulomas counted and measured. A, Representative 2D 1077 
scanned micrographs of granulomas inoculated with WT eggs (2 magnification) and 20 1078 
magnification (A1 and A2), and with Δω1 eggs; B, (2), B1 and B2 (20). C, control mouse 1079 
lung. D and E, Representative micrograph of individual, control eggs induced-granuloma that 1080 
was counted to assess for granuloma volume. F and G, Representative micrographs showing 1081 
Δω1 egg induced-granulomas. All single egg induced-granuloma from WT and Δω1 eggs were 1082 
measured and granuloma volume estimated. H, Scatter plots of the volume (mm3) for individual 1083 
granuloma, mean ± SE (red) are shown. The volumes of granulomas induced by Δω1 eggs were 1084 
significantly smaller than those surrounding WT eggs (Welch’s t-test, p ≤ 0.0001, n >100).  1085 
  1086 
Figure supplements 1087 
Figure 1—figure supplement 1. The T2 ribonuclease 1 is encoded by at least five gene copies 1088 
located on S. mansoni chromosome 1. A, The position of several genes coding for 1, including 1089 
Smp_179960, Smp_184360, Smp_193860 are shown, to indicate the physical relationship of the 1090 
copies on the chromosome. Two additional copies of 1, Smp_158430 and Smp_168300 do not 1091 
include the cognate sgRNA and PAM motifs. B, Map of gene structure and size of Smp_179960, 1092 
Smp_184360, Smp_193860, along with the 1-specific sgRNA target site. C, Normalized 1093 
expression of three copies of 1 as indicated throughout the developmental stages of S. mansoni. 1094 
The profile of developmental expression of 1 was established by meta-analysis of RNAseq 1095 
reads (79). 1096 
Figure 2—figure supplement 1. The nucleotide sequence of the Smp_193860 copy, and 1097 
indicates the UTR (green), coding exons (blue) and introns (red). 1098 
Figure 2— figure supplement 2.  Variation among copies of 1 in the reference genome of S. 1099 
mansoni. A, An alignment assembled using CLUSTALW (113) of the MiSeq amplicon region in 1100 
the 1 genes Smp_179960, Smp_184360, Smp_193860 and Smp_168300 using the sequences 1101 
from the S. mansoni genome, assembly V5. The MiSeq primers (highlighted in blue) and sgRNA 1102 
(red) were designed based on Smp_184360. Residues highlighted in green show where 1103 
Smp_168300 differs from the other three genes. B, An alignment made using CLUSTALW 1104 
(113) of the coding region of the amplicon sequence found in the gene Smp_193860 in the S. 1105 
mansoni V7 assembly, the predicted alternative sequence for the variant having ‘TT’ at position 1106 
60-61 and ‘TA’ at 152-153 in the amplicon (‘var’), and the translations of two mDNAs retrieved 1107 
from NCBI (top BLASTP hits in the NCBI protein database). Note that this corresponds to a part 1108 
only of the 1 T2 ribonuclease. The CAS-2 catalytic region is highlighted in red (32). The 1109 
mRNA XP_018647488.1 has an alternative splicing event at the start of the exon included in the 1110 
amplicon (shaded grey), so that it only matches the region from ‘KHEFEK…’ (in the CAS-2 1111 
catalytic region) onwards. C, An alignment of the coding region of the amplicon sequence in 1112 
schistosome 1 homologues (family 873078), excluding diverged members from S. japonicum 1113 
as well as the diverged S. haematobium gene B_00112. The region with sequence similarity to 1114 
the alternative splice-form is in shaded grey. Note that the Smp_193860 sequence used in this 1115 
alignment is the version in the S. mansoni draft genome V5 gene set, which has the Q->K 1116 
substitution at 152-153. 1117 
Figure 2— figure supplement 3. Programmed HDR-catalyzed knock-in of transgene into 1, 1118 
exon 6.  The PCR products visualized in ethidium bromide-stained agarose gel demonstrated 1119 
Cas9-catalyzed target site-specific insertional mutagenesis in exon 6 of the 1 gene. The 24 nt 1120 
transgene knocked-in into target site indicated in lanes R1, R2 and R3 of 321, 285 and 184 bp, 1121 
respectively (arrows at left) spanning the mutated site in the genomic DNAs pooled from 1122 
schistosome eggs, including a positive control flanking the insert site (991 bp).  Lanes 1-5 show 1123 
the amplicons from the control groups; medium only, sgRNA only, cas9 only, ssODN only and 1124 
heat-inactivated pLV-1X6+ssODN. Lanes 6-9 show the amplicons from experiment groups; 1125 
RNP, RNP and ssODN (KI), pLV-1X6virions, and pLV-1X6 virions and ssODN (KI).  1126 
Programmed knock-in was detected only in the KI experimental groups, as shown in lanes 7 and 1127 
9 where the transgene-specific amplicon obtained with the R1, R2 and R3 primers was present. 1128 
This product was not amplified by PCRs where DNAs from control and other experimental 1129 
groups served as the template. Amplicons of 991 bp were obtained with all genomic DNAs, 1130 
confirming the integrity of the genomic DNAs and the control amplicon primer pair. 1131 
Figure 2—figure supplement 4. Estimated relative copy number of 1. Copy number estimated 1132 
by qPCR in genomic DNAs isolated from CRISPR/Cas9-treated eggs or controls. The relative 1133 
copy number of the LE as calibrator sample = 1. Means ±SD of control (wt LE), LE treated- 1134 
Cas9 only, LE treated-ssODN only, LE treated-heat-inactivated pLV-⍵1X6 virions, LE treated-1135 
heat-inactivated pLV-⍵1X6 virions and ssODN, LE treated- pLV-⍵1X6 virions, LE treated-1136 
pLV-⍵1X6 virions and ssODN. 1137 
Figure 3— figure supplement 1. Quantitative PCR to estimate efficiency of programmed 1138 
mutagenesis. A, The three primers (tri-primer set): Sm1-OVR-F (probe at gRNA, expected 1139 
DSB and KI sites as red bar and arrow), Sm1-OUT-F and shared Sm1-reverse primer 1140 
locations used in SYBR green-based PCR to estimate efficiency of on-target, programmed 1141 
CRISPR/Cas9 gene editing. Estimation of gene-editing efficiency was determined as described 1142 
(50, 51). B, Relative fold amplification efficiency; the ratio of OVR:OUT (gray bar) was set at 1143 
100% for control DNA sample, and little or no reduction was observed in relative fold 1144 
amplification compared to other control groups, including groups exposed to culture medium 1145 
only, sgRNA only, Cas9 only, ssODN only, heat-killed pLV-ω1X6 virions and ssODN.  By 1146 
contrast, there was reduced relative fold amplification of 2.5%, 6.9%, 4.5% and 12.5% in the 1147 
experimental groups, RNP, RNP and ssODN, pLV-⍵1X6 virions, and pLV-⍵1X6virions and 1148 
ssODN, respectively. Percentages of relative fold amplification differed significantly among 1149 
control and experiment groups.  Means  SE were established from eleven biological replicates.  1150 
Figure 4— figure supplement 1. Levels of IL-2, IL-10 and IFN- following exposure to Δω1-1151 
SEA.  Levels of IL-2 (blue circle) and IL-10 (black square) were not significantly different 1152 
among groups after pulsing the Mϕ (PMA-induced THP-1 cells) with Δω1-SEA prior to co-1153 
culture with CD4+ T cells compared with WT-SEA pulsed-Mϕ.  IFN- (red triangle) was not 1154 
detected in any of the three groups. 1155 
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